Aripiprazole use in an individual with intellectual disability and schizoaffective disorder

Gerard Gallucci, Lawrence Mernaugh, Donald Dyson

Research output: Contribution to journalArticle

Abstract

The treatment of individuals with intellectual/developmental disabilities and schizophrenia or related disorders represents a challenge for clinicians. Individuals with cognitive impairment may be especially vulnerable to the adverse effects of conventional and atypical antipsychotic drugs. We report on the successful treatment of an individual with schizoaffective disorder and intellectual disability with aripiprazole, a novel antipsychotic agent with a favorable side effect profile.

Original languageEnglish (US)
Pages (from-to)53-56
Number of pages4
JournalMental Health Aspects of Developmental Disabilities
Volume7
Issue number2
StatePublished - Apr 2004

Fingerprint

Intellectual Disability
Psychotic Disorders
Antipsychotic Agents
Developmental Disabilities
Schizophrenia
Aripiprazole
Cognitive Dysfunction

Keywords

  • Aripiprazole
  • Atypical antipsychotics
  • Diabetes mellitus
  • Intellectual/developmental disability
  • Mental retardation
  • Psychiatric disorder
  • Schizoaffective disorder
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Aripiprazole use in an individual with intellectual disability and schizoaffective disorder. / Gallucci, Gerard; Mernaugh, Lawrence; Dyson, Donald.

In: Mental Health Aspects of Developmental Disabilities, Vol. 7, No. 2, 04.2004, p. 53-56.

Research output: Contribution to journalArticle

@article{5d366b1ac13b4957b2f7387bcefaeeab,
title = "Aripiprazole use in an individual with intellectual disability and schizoaffective disorder",
abstract = "The treatment of individuals with intellectual/developmental disabilities and schizophrenia or related disorders represents a challenge for clinicians. Individuals with cognitive impairment may be especially vulnerable to the adverse effects of conventional and atypical antipsychotic drugs. We report on the successful treatment of an individual with schizoaffective disorder and intellectual disability with aripiprazole, a novel antipsychotic agent with a favorable side effect profile.",
keywords = "Aripiprazole, Atypical antipsychotics, Diabetes mellitus, Intellectual/developmental disability, Mental retardation, Psychiatric disorder, Schizoaffective disorder, Schizophrenia",
author = "Gerard Gallucci and Lawrence Mernaugh and Donald Dyson",
year = "2004",
month = "4",
language = "English (US)",
volume = "7",
pages = "53--56",
journal = "Mental Health Aspects of Developmental Disabilities",
issn = "1057-3291",
publisher = "Psych-Media Inc.",
number = "2",

}

TY - JOUR

T1 - Aripiprazole use in an individual with intellectual disability and schizoaffective disorder

AU - Gallucci, Gerard

AU - Mernaugh, Lawrence

AU - Dyson, Donald

PY - 2004/4

Y1 - 2004/4

N2 - The treatment of individuals with intellectual/developmental disabilities and schizophrenia or related disorders represents a challenge for clinicians. Individuals with cognitive impairment may be especially vulnerable to the adverse effects of conventional and atypical antipsychotic drugs. We report on the successful treatment of an individual with schizoaffective disorder and intellectual disability with aripiprazole, a novel antipsychotic agent with a favorable side effect profile.

AB - The treatment of individuals with intellectual/developmental disabilities and schizophrenia or related disorders represents a challenge for clinicians. Individuals with cognitive impairment may be especially vulnerable to the adverse effects of conventional and atypical antipsychotic drugs. We report on the successful treatment of an individual with schizoaffective disorder and intellectual disability with aripiprazole, a novel antipsychotic agent with a favorable side effect profile.

KW - Aripiprazole

KW - Atypical antipsychotics

KW - Diabetes mellitus

KW - Intellectual/developmental disability

KW - Mental retardation

KW - Psychiatric disorder

KW - Schizoaffective disorder

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=2942570081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942570081&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:2942570081

VL - 7

SP - 53

EP - 56

JO - Mental Health Aspects of Developmental Disabilities

JF - Mental Health Aspects of Developmental Disabilities

SN - 1057-3291

IS - 2

ER -